FBO#5678
A - Research and Development
FEDBIZOPPS: AWARDS - June 10, 2017
- HR0011-17-C-0071 - Phase 0/CLIN 1: $978,149; Phase 1 Design/CLIN 2: $474,233; Phase 1 Design Opt/CLIN 3: $1,881,678; Phase 1 Demo/CLIN 4: $4,760,426; Phase 2 Demo/CLIN 5: $2,046,475; TA3 Phase 1/CLIN 6: $588,873; TA3 Phase 2/CLIN 7: $486,849, TA3 Phase 3/CLIN 8: $407,734
RECONFIGURABLE IMAGING (REIMAGINE)
Northrop Grumman Systems Corporation, 1580A W Nursery Rd., Linthicum Heights, Maryland 21090-2202, United States
- HR001117C0104 - $115,939.88.
IMPROVING SOCIAL SCIENCE ON NUCLEAR ISSUES WITH QUASI-EXPERIMENTAL SIMULATION.
Mckinsey & Company, Inc. Washington, D.C.
- N00014-17-D-1001 - $9,999,999.00
PROGENY SYSTEMS CORPORATION
PROGENY SYSTEMS CORPORATION<br />9500 INNOVATION DRIVE<br />MANASSAS<br />VA<br />20110<br />USA
| This Issue's Index | Today's FBO Daily Index Page |
Created on 09-Jun-2017 by Loren Data Corp. -- info@fbodaily.com